Corinna Tsieh, NP

Corinna Tsieh practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Corinna Tsieh's NPI, 1528771854, was assigned on January 2, 2023. Corinna Tsieh holds California license 95022148.

Corinna Tsieh's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Corinna Tsieh's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Corinna Tsieh to 5 more medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Corinna Tsieh practices, 3 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Corinna Tsieh's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Corinna Tsieh is licensed in California.

Dmand AI lists high cholesterol, joint pain and tobacco use among the conditions Corinna Tsieh treats.

CMS data shows 447 Medicare services from Corinna Tsieh across 3 procedure codes in 2024, for 122 Medicare patients. Medicare paid $36,779 for them. Every service was in an office.

CMS counts 122 Medicare patients who saw Corinna Tsieh in 2024. The largest group is 75 to 84, with 54 patients. 75% of them have cancer, and 75% have high blood pressure. Their average risk score is 2.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Corinna Tsieh's median patient age at 69, with 54% women.

In 2024, Corinna Tsieh wrote 755 Medicare Part D claims for 213 patients. 74% of them were for generic drugs. CMS names the drug for 548 of them, across 21 drugs with 11 or more claims each, at $1,817,223 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Corinna Tsieh for performance year 2024, reported as part of a group. Corinna Tsieh accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Corinna Tsieh as offering telehealth.

CMS Open Payments shows 1 general payment to Corinna Tsieh from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Ipsen Biopharmaceuticals, Inc paid the most, $98.